
Abbisko Therapeutics Signs Multi-Target Medicine Deal With Eli Lilly Worth Up to $1.9 Billion
Prime Highlights Eli Lilly and Abbisko Therapeutics signed a deal worth up to $1.9 billion

Prime Highlights Eli Lilly and Abbisko Therapeutics signed a deal worth up to $1.9 billion

Prime Highlights UPS is investing $48 million in 27 temperature-controlled facilities across the Americas, Europe,

Prime Highlights Researchers found that boosting trust in healthcare systems had the greatest impact on

Prime Highlights noris network shifted a leading German healthcare organisation to a sovereign cloud platform

Prime Highlights Moderna has appointed Ester Banque as CCO and expanded president Stephen Hoge’s remit

Prime Highlights The MHRA is launching an AI regulatory sandbox to help identify drug safety

Prime Highlights FDA approved Tzield for children recently diagnosed with stage 3 diabetes. Tzield carries

Prime Highlights New Jersey has launched the World Cup 2026 Health Hub, a digital platform

Prime Highlights 27% of clinicians said AI helped identify potential medical errors at least three

Prime Highlights- The FDA approved Pfizer’s Hympavzi for children with hemophilia B aged 6 to